Status: Recruiting
Clinical Evaluation of 177Lu-FAP-VG11 Injection in Patients With Fibroblast Activation Protein -Positive Advanced Solid Tumours
This is an exploratory clinical study evaluating the safety, tolerability and biodistribution characteristics of 177Lu-FAP-VG11 injection in patients with FAP-positive advanced solid tumours.
Participants needed: 7
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Shandong Cancer Hospital and InstituteUpdated: Sep 14, 2026Locations: 1
Eligibility criteria
Patients with advanced solid tumors who have failed standard therapy or for whom... [+9]
Clinically symptomatic central nervous system metastases or meningeal metastases... [+7]